Clinical trial
Investigating the Effect of Exosome Derived From Human Fetal Umbilical Cord Mesanchymal Cells as Complimintary Treatment in Moderate to Severe Erectile Dysfunction
NCT07319533 is registered in ClinicalTrials.gov with Labbafinejad Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Effect of Exosome Derived From Human Fetal Umbilical Cord Mesanchymal Cells as Complimintary Treatment in Moderate to Severe Erectile Dysfunction
- Lead sponsor
- Labbafinejad Medical Center
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- January 31, 2026
- Completion date
- January 31, 2027
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
erectile dysfunction, erectile dysfunction associated with type 2 diabetes mellitus, erectile dysfunction due to arterial disease, erectile dysfunction due to arterial insufficiency, erectile dysfunction due to general medical condition, erectile dysfunction due to neuropathy